The most important part of this eNews? We're grateful for YOU! In our Thanksgiving edition, read more about how Cool Comedy • Hot Cuisine is helping us move research forward,...
Read More
In this month's eNews, learn more about the first-ever recipient of the Bob Saget Legacy Award, the new industry partner joining the CONQUEST platform clinical trial, a golfing fundraiser for...
Read More
SAN FRANCISCO, October 3, 2023 — The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Boehringer Ingelheim, a leading research-driven biopharmaceutical company, will…
Just a little less than two months until our signature fundraiser, Cool Comedy • Hot Cuisine, a Tribute to Bob Saget--and this eNews shares who's performing! In addition, learn more...
Read More
Exciting news—Regina Hall represented the Scleroderma Research Foundation as our Ambassador for CF Charity Day yesterday! Since September 11, 2001, Cantor Fitzgerald commemorates their 658 employees lost in the World Trade…
It's that time--this month's eNews is now available to read online. Learn more about how we've launched a highly innovative platform clinical trial, CONQUEST. And, registration is now open for...
Read More
In 2015, Mercy began to notice changes in her health. However, it wasn’t until 2017 that she received a definitive diagnosis: scleroderma. “I was progressing pretty quickly at the time,”…
• Sanofi is inaugural partner • Initial focus on Interstitial Lung Disease Secondary to Scleroderma • SRF will submit and hold the IND as the trial Sponsor SAN FRANCISCO, August...
Read More
Today, the Scleroderma Research Foundation announces the launch of CONQUEST, a highly innovative platform clinical trial designed to rapidly advance promising treatments for scleroderma. Industry partner, Sanofi, will contribute the first experimental...
Read More
This month's eNews contains a big announcement--find out who is the first ever recipient of the Bob Saget Legacy Award. And don't miss the rest of these stories, like why...
Read More
